T1	Participants 123 153	high-risk haematology patients
T2	Participants 257 316	haematology patients at high risk of invasive aspergillosis
T3	Participants 616 773	eligible patients were adults undergoing allogeneic stem-cell transplantation or chemotherapy for acute leukaemia, with no history of invasive fungal disease
T4	Participants 1801 1865	240 eligible patients were recruited from six Australian centres
